Interesting piece on the challenges facing those trying to gain approval for new treatments for rare diseases. In rare diseases more than...

Perhaps at the cellular level, for now.  Researchers based in the UK recently discovered a way to switch on cell splicing factors –...

In 2012, IBM estimated that 2.5 exabytes (i.e., 2.5 billion gigabytes) of data was generated every day. What that figure is today has...

My granddad used to have one of those a biscuit tins, the ones most of us recognise as a sewing box. After every meal my siblings or I...

Abilify MyCite, a combination of Otsuka's Abilify and Proteus Digital Health's ingestible sensor, provides the ability to track the...

Here’s a fascinating piece about a new approach to helping non-sufferers really KNOW what it’s like to experience the symptoms of a...

In this March 2017 article in Forbes magazine, contributor Daniel Newman speculates that increasing integration of digital technology...

The genome editing technology ‘Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR, pronounced ‘crisper’)’, was in the news...

Antibiotic resistance is the ability of microbes to survive antibiotic treatment. It is an inevitable consequence of the “Red Queen”...

Whilst GP surgeries were one of the first sectors to fully implement the use of computers to log personal information, calls to open...

Digoxin (digitalis, a purified product of the foxglove plant) has been around for nearly a century and is ‘cheap as chips’. It is...

The Orphan Drug Tax Credit has assisted in the creation of an increased number of orphan drug treatments since its inception in 1983 but...

Continuing the dive into the impact of the human microbiome on the development of non-gastro-intestinal diseases and to follow up on last...

Artificial grafts, which are commonly used in kidney dialysis patients, currently lead to approximately 50% of patients experiencing...

Immuno-oncology has frequently been hailed as the ‘new frontier’ in oncological medicine, with many millions being invested by...

The implications of microbiome in cancer treatment first came to my attention at a plenary talk by Jennifer Wargo at the NCRI conference...

Though a person's microbiome is generally stable throughout his/her lifetime, there are notable differences from person to person. Though...

Retrotope is a clinical-stage company, within the area of degenerative disease. Their first first lead candidate, RT001, today became an...

Regulatory T cells  (Tregs; pronounced 'tee-regs'), are a critical negotiator in the body’s immune response. ‘Killer’ and ‘helper’ T...

Earned media and public campaigns have traditionally been left to patient support groups looking to raise money and awareness for...

I recently wrote a short piece on whether I should continue taking PPIs (proton pump inhibitors) as the growing evidence base seems to...